Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Inhibiting TYK2 can restore hair growth in alopecia areata.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

JAK inhibitors may help treat alopecia areata by restoring hair growth.

JAK inhibitors may help treat alopecia areata by restoring hair growth.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Infections and missed treatments trigger flares in alopecia areata patients on JAK inhibitors.

Vitamin C derivative helps hair grow longer by making cells produce a growth factor through a specific cellular pathway.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

IL-1β inhibits human hair follicle growth.

Researchers developed a scaffold that releases a healing drug over time, improving wound healing and skin regeneration.

DA-9401 helps protect rat testis from finasteride damage.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Ginsenoside Rg3 from Panax ginseng can lighten skin by reducing melanin production.

High doses of cobalt stopped hair growth in rabbits.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib can help about 14,000 people with severe hair loss.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.